Core Outcomes Set for Trials in People With Coronavirus Disease 2019
2020 · Critical Care Medicine · 66 citations
https://doi.org/10.1097/ccm.0000000000004585
E
Ella Flemyng
Cochrane(GB)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
38
Papers
1.5K
Citations
12
h-index
15
i10-index
Ella Flemyng is an academic researcher from Cochrane. The author has contributed to research in topics: Meta-analysis and systematic reviews & Health Systems, Economic Evaluations, Quality of Life & Delphi Technique in Research. The author has an h-index of 12, co-authored 33 publications.
ORCID: 0000-0002-9845-9076Papers by this author
worksProtocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions
2024 · BMJ Open · 37 citations
https://doi.org/10.1136/bmjopen-2024-084164
A survey of experts to identify methods to detect problematic studies: stage 1 of the INveStigating ProblEmatic Clinical Trials in Systematic Reviews project
2024 · Journal of Clinical Epidemiology · 10 citations
https://doi.org/10.1016/j.jclinepi.2024.111512
Abstracts from the NIHR INVOLVE Conference 2017
2017 · Research Involvement and Engagement · 8 citations
https://doi.org/10.1186/s40900-017-0075-x
Developing the infrastructure for patient review in academic journals
2018 · Research Involvement and Engagement · 5 citations
https://doi.org/10.1186/s40900-018-0114-2
Position statement on artificial intelligence (AI) use in evidence synthesis across Cochrane, the Campbell Collaboration, JBI and the Collaboration for Environmental Evidence 2025
2025 · Environmental Evidence · 2 citations
https://doi.org/10.1186/s13750-025-00374-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat